Preparation method and application of chiral 5-oxopyrrolidine-3-carboxylic acid

Chiral 5-oxygen was successfully prepared by the reaction of dimethyl itaconic acid and R(+)-p-methoxymethylbenzylamine and silica gel column chromatography, combined with the treatment of lithium hydroxide and cerium nitrate. Pyrrolidine-3-formic acid solves the problems of intermediate purity and separation difficulty in the prior art, and realizes efficient preparation of drug intermediates.

CN115197115BActive Publication Date: 2024-11-08CHENGDU JINBO HUIKANG PHARM TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211025942.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-08-25
Publication Date
2024-11-08
Estimated Expiration
2042-08-25

AI Technical Summary

Technical Problem

The prior art is difficult to effectively prepare chiral 5-oxopyrrolidine-3-formic acid, which leads to the difficulty of optical purity and separation and purification of the intermediate, limiting its application in the field of medicinal chemistry.

Method used

Dimethyl itaconic acid and R(+)-p-methoxymethylbenzylamine were heated at 180°C, and diastereoisomers were separated by silica gel column chromatography, followed by ester hydrolysis and nitrogen removal. The protective group is used to react lithium hydroxide and cerium nitrate to gradually obtain chiral 5-oxopyrrolidine-3-formic acid, thereby improving optical purity.

Benefits of technology

The high optical purity separation and purification of chiral compounds is achieved, the process route is simplified, the cost is reduced, the chemical yield is improved, and the application value of drug synthesis is extensive.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115197115B_ABST
    Figure CN115197115B_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of medicinal chemistry and preparation of organic chiral compounds, and particularly relates to a preparation method and application of chiral 5-oxopyrrolidine-3-carboxylic acid. The method of the invention uses dimethyl itaconate (CAS: 617-52-7) and R(+)-p-methoxymethylbenzylamine (CAS: 22038-86-4) as starting materials to react to prepare a pair of diastereomers, which are then separated by ordinary silica gel column chromatography to obtain the two diastereomers; the two diastereomers are then subjected to chemical reactions respectively, and target chiral compounds (R)-A and (S)-A of two configurations are obtained by ester hydrolysis and removal of nitrogen protecting groups, or first removal of nitrogen protecting groups and then ester hydrolysis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of medicinal chemistry and preparation of organic chiral compounds, and particularly relates to a preparation method and application of chiral 5-oxopyrrolidine-3-carboxylic acid. Background Art

[0002] 5-Oxopyrrolidine-3-carboxylic acid (chemical structure as follows: A) is an important class of drug intermediates. For example, N-alkyl or benzyl substituted 5-oxopyrrolidine-3-carboxylic acid is an essential intermediate raw material for the synthesis of the anti-Alzheimer's drug Neracetam; Neracetam is a new drug with a pyrrolidone structure (Nebracetam), which has the function of improving brain energy metabolism and neurotransmission, and has a significant improvement effect on the dysfunction of the brain's cholinergic system; and chiral R / S configuration 5-oxopyrrolidine-3-carboxylic acid can be used to prepare new pyrrolidone derivatives.

[0003]

[0004] The chemical name of 5-oxopyrrolidine-3-carboxylic acid can also be named as 2-pyrrolidinone-4-carboxylic acid. In patent CN104447733A, researchers chemically coupled 1-benzyl-2-pyrrolidinone-4-carboxylic acid (1-benzyl-5-oxopyrrolidine-3-carboxylic acid) with the main pharmacophoric group fragment 5-aromatic aminoacyl-2-aminothiazole of the protein kinase inhibitor anti-tumor drug Dasatinib to obtain 1-benzyl-2-pyrrolidinone-4-amide compounds.

[0005] This type of 2-pyrrolidone-4-amide compound with the dasatinib pharmacophore can effectively regulate the signal transduction of tyrosine kinase, inhibit the proliferation of adverse cells and angiogenesis, and has a significant anti-tumor activity.

[0006] In summary, 5-oxopyrrolidine-3-carboxylic acid (2-pyrrolidone-4-carboxylic acid) is a key intermediate for the synthesis of nootropic drugs and anti-tumor compounds. It can be foreseen that chiral R or S-configured 5-oxopyrrolidine-3-carboxylic acid will have important practical value and broad application prospects in the field of medicinal chemistry. Therefore, it is necessary to provide a preparation method and application of chiral R or S-configured 5-oxopyrrolidine-3-carboxylic acid. Summary of the invention

[0007] In order to solve the above technical problems, the present invention provides a preparation method and application of chiral 5-oxopyrrolidine-3-carboxylic acid, introduces a chiral center, and each chiral intermediate product is easy to separate and purify and has a high optical purity.

[0008] In order to achieve the technical effect of solving the above technical problems, the present invention is realized by the following technical aspects: a method for preparing chiral 5-oxopyrrolidine-3-carboxylic acid, characterized in that it specifically comprises the following steps:

[0009] S1. Use the starting materials dimethyl itaconate (CAS: 617-52-7) and R(+)-p-methoxymethylbenzylamine (CAS: 22038-86-4) to heat the reaction at 180°C.

[0010] As a preferred method, since both raw materials are liquid, no other organic solvent is used, and the methanol (CH 3 OH) in order to promote the reaction to be more complete; the equivalent molar ratio of the reaction substrates dimethyl itaconate and R(+)-p-methoxymethylbenzylamine is 1:1; the reaction product is a mixture of a pair of diastereomers.

[0011] S2. Separating a pair of diastereoisomers generated in the first step reaction by using ordinary silica gel column chromatography.

[0012] The chemical names of the two chiral compounds isolated are (1R, 3R)-1-(1-(4-methoxyphenyl)ethyl)-5-oxopyrrolidine-3-carboxylic acid methyl ester and (1R, 3S)-1-(1-(4-methoxyphenyl)ethyl)-5-oxopyrrolidine-3-carboxylic acid methyl ester, respectively. The chemical yields of the two chiral compounds are more than 60%, and their de values ​​are greater than 90% as analyzed by high pressure liquid chromatography (HPLC).

[0013] Preferably, the eluent used for column chromatography is preferably petroleum ether (60-90°C) and ethyl acetate, with the ratio (volume ratio) being 3:1, 2:1, 1:1, and 1:2 respectively; petroleum ether (60-90°C) can also be used in the range of 30-60°C, or can be replaced by n-hexane; the silica gel used for column chromatography can be 100-200 mesh or 200-300 mesh, preferably 200-300 mesh.

[0014] S3. The two diastereomers separated in the previous step are further reacted to obtain target chiral compounds (R)-A and (S)-A in two configurations by ester hydrolysis and removal of nitrogen protecting groups, or by first removing the nitrogen protecting groups and then hydrolyzing the esters.

[0015] Preferably, the two diastereomers separated by column in S2 are oily substances, and the molar ratio of the two diastereomers to lithium hydroxide (LiOH) is 1:1-1:1.5. The reaction uses a mixed solvent of methanol and water (volume ratio 1:1), the reaction temperature is room temperature 20-25°C, the reaction time is generally 2-3 hours, and the chemical yield of the hydrolysis reaction exceeds 85%; the names of the two products are (1R, 3R)-1-(1-(4-methoxyphenyl)ethyl)-5-oxopyrrolidine-3-carboxylic acid and (1R, 3S)-1-(1-(4-methoxyphenyl)ethyl)-5-oxopyrrolidine-3-carboxylic acid; since the two carboxylic acid intermediates are solid, their optical purity can be increased by recrystallization.

[0016] As a preferred embodiment, the carboxylic acid products are also diastereoisomers of each other, and are respectively reacted with rare earth compounds cerium nitrate ammonium (Ce(NH 4 ) 2 (NO 3 ) 6 ) reaction, removing the protecting group on N (generating p-methoxyacetophenone) to obtain (3R) 5-oxopyrrolidine-3-carboxylic acid and (3S) 5-oxopyrrolidine-3-carboxylic acid; the molar ratio of the chiral carboxylic acid substrate to cerium nitrate ammonium is 1:1-1:2, preferably 1:1.5; the solvent is acetonitrile and water (volume ratio 1:1), the reaction temperature is room temperature 20-25°C, and the reaction time is 0.5-1.5 hours, preferably 1 hour.

[0017] Preferably, the product (1R, 3R) or (1R, 3S)-1-(1-(4-methoxyphenyl)ethyl)-5-oxopyrrolidine-3-carboxylic acid methyl ester in S2 can also be reacted with cerium nitrate in acetonitrile and water to remove the protecting group on N to obtain two chiral 5-oxopyrrolidine-3-carboxylic acid methyl esters of configuration (3R or 3S), which are also two solids and can be purified by recrystallization to improve their optical purity; the chemical reaction conditions are the same as those described in (2). Then, lithium hydroxide is used in methanol and water as solvents to hydrolyze the methyl ester to obtain two target products (3R) 5-oxopyrrolidine-3-carboxylic acid and (3S) 5-oxopyrrolidine-3-carboxylic acid, respectively; the chemical reaction conditions are the same as those described in (1); the chemical yields are also similar.

[0018] Another object of the present invention is to provide an application of chiral 5-oxopyrrolidine-3-carboxylic acid.

[0019] The beneficial effects of the present invention are:

[0020] 1. The method of the present invention uses the chiral compound R(+)-p-methoxymethylbenzylamine (CAS: 22038-86-4) as a raw material for the first time, and introduces a chiral central carbon atom after reacting with dimethyl itaconate; and the p-methoxy group of the benzene ring increases the polarity of the intermediate product, which is beneficial to post-treatment and purification and separation of diastereoisomers, and has certain innovation.

[0021] 2. The pair of chiral diastereomers generated in the first step can be easily separated by ordinary silica gel column chromatography, avoiding the use of other cumbersome and expensive methods and reagents such as chiral separation or chiral preparative chromatography, and the optical purity (de value) of the two chiral intermediates exceeds 90%.

[0022] 3. After separation and purification, the first chiral compound is further hydrolyzed with lithium hydroxide (LiOH) to obtain (1R, 3R) or (1R, 3S)-1-(1-(4-methoxyphenyl)ethyl)-5-oxopyrrolidine-3-carboxylic acid, which is a solid and can be purified by recrystallization to improve its optical purity (de value). Similarly, the two chiral (3R / 3S)-5-oxopyrrolidine-3-carboxylic acid methyl esters obtained by reacting with cerium nitrate ammonium to remove the protecting group on N are also solids and can also be easily purified by recrystallization to increase their optical purity (ee value). This effectively ensures the optical purity of the final product (3R) / (3S)-5-oxopyrrolidine-3-carboxylic acid.

[0023] 4. The synthesis process of the present invention is novel, the raw materials and reagents are cheap and easily available, the post-treatment is convenient, the reaction conditions are mild, and the chemical yield is high; in particular, the chiral center is cleverly introduced, and each chiral intermediate product is easy to separate and purify, and has a high optical purity; it has wide application value and potential in the synthesis of chiral drugs. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the accompanying drawings required for describing the embodiments will be briefly introduced below. Obviously, the accompanying drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other accompanying drawings can be obtained based on these accompanying drawings without paying creative work.

[0025] Figure 1 Schematic diagram of the chemical structure of

[0026] Figure 2 It is the chemical reaction formula of dimethyl itaconate (CAS: 617-52-7) and R(+)-p-methoxymethylbenzylamine (CAS: 22038-86-4) heated at 180°C;

[0027] Figure 3It is a chemical reaction formula obtained by ordinary silica gel column chromatography separation method;

[0028] Figure 4 The chemical reaction formula is that two diastereoisomers continue to react, undergo ester hydrolysis and remove the nitrogen protecting group, or first remove the nitrogen protecting group and then hydrolyze the ester to obtain two configurations of the target chiral compounds (R)-A and (S)-A; DETAILED DESCRIPTION

[0029] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0030] Example 1

[0031] 15.85 g of dimethyl itaconate (0.1 mol) and 15.12 g of R(+)-p-methoxymethylbenzylamine (0.1 mol) were weighed and added to a round-bottom flask, and the mixture was heated in a silicone oil bath at 180° C. for 2-3 hours, and the methanol generated by the reaction was separated by a water separator. The two raw material spots disappeared on a thin layer plate spot (TLC), and about 3.5-4.0 ml of methanol was separated, and the reaction was terminated at this time. After the reaction oil residue was cooled, it was directly separated by column chromatography using 200-300 mesh ordinary silica gel, and petroleum ether (60-90° C.) and ethyl acetate were used as eluents in sequence, and the volume ratio (ethyl acetate: petroleum ether) was gradient eluted from 1:3, 1:2, 1:1, and 2:1, and the product of the upper fluorescent spot and the product of the lower fluorescent spot of TLC were collected respectively. The solvent was evaporated by a reduced pressure rotary evaporator to obtain 8.7 g of the upper product with less polarity, with a yield of 62.8%; and 9.5 g of the lower product with greater polarity, with a yield of 68.6%.

[0032] The optical purity de value was determined by high pressure liquid chromatography (HPLC) using a C-18 ordinary chromatographic column with n-hexane and methanol as mobile phases. The de values ​​of the diastereoisomers were 93.56% for the less polar product and 95.23% for the more polar product. It is worth pointing out that we cannot correspond the less polar or more polar products in the chromatogram (TLC & HPLC) to their absolute configuration products, i.e., (1R, 3R) or (1R, 3S) 1-(1-(4-methoxyphenyl)ethyl)-5-oxopyrrolidine-3-carboxylic acid methyl ester.

[0033] H NMR spectroscopy ( 1 HNMR-CDCl 3)Structural identification: (1) Less polar product: δ(ppm): 1.50(d, 3H), 2.63-2.78(m, 2H), 3.09(q, 1H), 3.18(t, 1H), 3.52(dd, 1H), 3.72(s, 3H), 3.80(s, 3H), 5.44(q, 1H), 6.86(d, 2H), 7.22(d, 2H). (2) More polar product: δ(ppm): 1.51(d, 3H), 2.63-2.78(m, 2H), 3.08-3.22(m, 2H), 3.52(m, 1H), 3.65(s, 3H), 3.80(s, 3H), 5.45(q, 1H), 6.86(d, 2H), 7.22(d, 2H). From the hydrogen spectrum, we can see that the chemical shifts of the methyl hydrogen atoms of the para-methoxy group of the benzene ring are obviously different, the less polar one is at 3.72 ppm, and the more polar one is at 3.65 ppm. 1 The HNMR spectrum is a distinct signature for distinguishing the two chiral diastereomers.

[0034] Example 2

[0035] Take 4.8 g (17.3 mmol) of the less polar product of the previous step, 1-(1-(4-methoxyphenyl)ethyl)-5-oxopyrrolidine-3-carboxylic acid methyl ester, dissolve the oil in 20 mL of methanol, add 20 mL of water and stir evenly, weigh LiOH 0.65 g (27.1 mmol). If the amount of lithium hydroxide is small, the solid can be added directly and slowly. If the amount is large, it can be dissolved in an appropriate amount of water and then added dropwise. Stir the reaction at room temperature for 3-4 hours, and terminate the reaction after the TLC spot plate detects the disappearance of the substrate spot. Adjust the pH of the reaction solution to 5-6 with 10% hydrochloric acid, evaporate the methanol, add an appropriate amount of water and extract with ethyl acetate three times, combine the organic layers, wash with saturated brine and water once, dry with anhydrous sodium sulfate or anhydrous magnesium sulfate, and rotary evaporate the organic solvent to obtain a light yellow solid. The solid is recrystallized from a mixed solvent (n-hexane: tetrahydrofuran = 1:1) to form white crystals, stand and filter, concentrate the mother liquor to precipitate solid crystals again, filter, combine and dry to weigh a total of 4.1 g, and the chemical yield is 89.9%.

[0036] H NMR spectroscopy ( 1 HNMR-CDCl 3)、δ(ppm):1.50(d, 3H), 2.70-2.84(o&qq, 2H),3.09-3.16(m, 1H), 3.18-3.23(t, 1H), 3.56-3.60(q, 1H), 3.78(s, 3H), 5.45(q,1H), 5.78(br, 1H, COOH), 6.87(d, 2H), 7.22(d, 2H). Carbon NMR 13 CNMR (CDCl 3 ), δ(ppm): 16.10, 34.38, 35.86, 44.48, 48.94, 55.26, 114.01, 128.34,131.27, 159.05, 172.41, 176.21.

[0037] Using the same reaction method, conditions and post-treatment, 4.5 g of the methyl carboxylate isomer with a larger polarity was hydrolyzed with lithium hydroxide to obtain 3.8 g of a white solid carboxylic acid product with another configuration, with a chemical yield of 88.9%. 1 HNMR-CDCl 3 )、δ(ppm):1.51(d, 3H), 2.69-2.84(m, 2H), 3.08-3.13(m, 1H), 3.18-3.24(m, 1H), 3.52-3.60(m, 1H), 3.80(s, 3H), 5.44(q, 1H), 6.40(br, 1H, COOH),6.86(d, 2H), 7.22(d, 2H). 13 CNMR (CD Cl 3 ), δ(ppm): 16.43, 34.56, 35.89, 44.68, 49.02, 55.38, 114.01, 128.34, 131.47, 159.13, 172.62, 176.32. Example 3

[0038] Take about 2.5 g (9 mmol) of either of the two chiral isomers in Example 1, add 40 mL of acetonitrile and 40 mL of water to dissolve and stir evenly, weigh 8.1 g (15 mmol) of cerium nitrate ammonium and add it in batches, stir at room temperature for about 1 hour, the color of the reaction solution changes from brown red to reddish yellow and then to bright yellow, the TLC spot plate detection raw material spot disappears, then add 30 mL of NaHCO 3The reaction was terminated with aqueous solution, part of acetonitrile was evaporated under reduced pressure, and an appropriate amount of water was added and then extracted with ethyl acetate for three times. The combined organic layers were washed with water twice, dried over anhydrous sodium sulfate or anhydrous magnesium sulfate, and the organic solvent was rotary evaporated to obtain a jelly; the jelly was separated by rapid silica gel column chromatography, first using petroleum ether (60-90°C) and ethyl acetate (5:1) as eluent, and the product with strong fluorescent spots on it was collected, evaporated to dryness and sent to 1 HNMR (CDCl 3 ) was identified as the by-product p-methoxyacetophenone; finally, ethyl acetate: dichloromethane (volume ratio 1:1) was used to elute the following product spot (iodine color development), and after combining, the solvent was evaporated to obtain about 1.05 grams of white solid with a yield of 81.4%. The product was identified as (3R / 3S)-5-oxopyrrolidine-3-carboxylic acid methyl ester by nuclear magnetic resonance spectroscopy.

[0039] H NMR spectroscopy ( 1 HNMR-CDCl 3 ), δ(ppm): 2.54-2.70(o, 2H), 3.12-3.40(q, 1H), 3.59-3.67(m, 2H), 3.75(s, 3H), 6.96(br, 1H, NH).

[0040] C NMR spectroscopy ( 13 CNMR, CD Cl 3 ), δ(ppm): 33.15, 38.77, 44.40, 52.45,173.16, 176.66. Example 4

[0041] The product (1R, 3R) or (1R, 3S)-1-(1-(4-methoxyphenyl)ethyl)-5-oxopyrrolidine-3-carboxylic acid in Example 2 was oxidized with cerium nitrate amine in Example 3 to remove the N-protecting group, thereby obtaining the chiral target product (3R) / (3S)-5-oxopyrrolidine-3-carboxylic acid (gum). The product (3R / 3S)-5-oxopyrrolidine-3-carboxylic acid methyl ester in Example 3 was hydrolyzed with lithium hydroxide in Example 2 to remove the methyl ester, thereby also obtaining the chiral target product (3R) / (3S)-5-oxopyrrolidine-3-carboxylic acid (gum).

[0042] In the description of this specification, the description with reference to the terms "one embodiment", "example", "specific example", etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner.

[0043] The preferred embodiments of the present invention disclosed above are only used to help illustrate the present invention. The preferred embodiments do not describe all the details in detail, nor do they limit the invention to the specific implementation methods described. Obviously, many modifications and changes can be made according to the content of this specification. This specification selects and specifically describes these embodiments in order to better explain the principles and practical applications of the present invention, so that those skilled in the art can understand and use the present invention well. The present invention is limited only by the claims and their full scope and equivalents.

Claims

1. A method for preparing chiral 5-oxopyrrolidine-3-carboxylic acid, characterized in that: The specific steps include: S1, using dimethyl itaconate and R(+)-p-methoxymethylbenzylamine as starting materials to react and prepare a pair of diastereomers; S2, separated by ordinary silica gel column chromatography to obtain the two diastereomers; S3, continuing chemical reaction with the two diastereomers respectively, through ester hydrolysis and removal of nitrogen protecting group, or first removing the nitrogen protecting group and then hydrolyzing the ester, to obtain two chiral target compounds (3R)-5-oxopyrrolidine-3-carboxylic acid ((R)-A) and (3S)-5-oxopyrrolidine-3-carboxylic acid ((S)-A); The reaction conditions of the two starting materials in S1 are heating at 180° C. for 2-3 hours and fractionating the generated methanol; The purification and separation method for the two diastereomers generated after the reaction of the two raw materials in S2 is ordinary silica gel column chromatography, and the eluent used in the column chromatography is petroleum ether and ethyl acetate, and the volume ratio is 3:1, 2:1, 1:1, 1:2 respectively; the silica gel used in the column chromatography is 100-200 mesh or 200-300 mesh; The hydrolysis method of the carboxylic acid methyl ester in S3 adopts lithium hydroxide (LiOH), the molar ratio of carboxylic acid methyl ester to lithium hydroxide (LiOH) is 1:1-1:1.5, the solvent is methanol and water, the volume ratio is 1:1, the reaction temperature is room temperature, and the reaction time is 2-3 hours; The removal of the protecting group on the nitrogen atom in S3 uses the rare earth compound cerium nitrate ammonium (Ce(NH4)2(NO3)6), the molar ratio of the chiral carboxylic acid substrate to cerium nitrate ammonium is 1:1-1:2, the solvent is acetonitrile and water, the volume ratio is 1:1, the reaction temperature is room temperature, and the reaction time is 0.5-1.5 hours; The diastereoisomer structures in S2 are: (1R, 3R)-1-(1-(4-methoxyphenyl)ethyl)-5-oxopyrrolidine-3-carboxylic acid methyl ester and (1R, 3S)-1-(1-(4-methoxyphenyl)ethyl)-5-oxopyrrolidine-3-carboxylic acid methyl ester.